Marta Krawczyk

7PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionHaematological tumoursMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2026
Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

|Jan 10, 2026
Beyond Biochemical Markers: Characterizing Malnutrition in COVID-19.

Katarzyna Plewka-Barcik, Maria Różańska-Trzepla, Krzysztof Kłos

|Apr 04, 2025
LILRB1-directed CAR-T cells for the treatment of hematological malignancies.

Katsiaryna Marhelava, Klaudyna Fidyt, Monika Pepek

|Mar 31, 2025
Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin.

Joanna Domagala, Tomasz M Grzywa, Iwona Baranowska

|Jun 10, 2022
CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies.

Katsiaryna Marhelava, Marta Krawczyk, Malgorzata Firczuk

|Apr 12, 2022
CD14 recycling modulates LPS-induced inflammatory responses of murine macrophages.

Anna Ciesielska, Marta Krawczyk, Hanna Sas-Nowosielska

Pageof 2

Frequent Collaborators

2 joint publications

Aleksandra Kusowska

2 joint publications

Malgorzata Bobrowicz

2 joint publications

Narcis Fernandez-Fuentes

2 joint publications

Monika Pepek